An atypical presentation of Sweet’s syndrome in a myelofibrosis patient
An atypical presentation of Sweet’s syndrome in a myelofibrosis patient
复制标题
骨髓纤维化患者 Sweet 综合征的非典型表现
DOI:
10.1136/bcr-2018-228076
复制
发表时间:
2019
期刊:
影响因子:
0.9
通讯作者:
Faysal Haroun
中科院分区:
文献类型:
--
作者:
Umera Thebo;S. Tummala;Samah Nassereddine;Faysal Haroun
A 46-year-old man with no significant medical history presented to haematology with symptoms of fatigue, dyspnoea on exertion and weight loss. Physical examination revealed a lesion on the right shin and splenomegaly. Labs were significant for leucocytosis with immature components, thrombocytosis and 3% peripheral blasts on smear. A bone marrow biopsy confirmed a diagnosis of myelofibrosis (MF). Dynamic International Prognosis Scoring system was 2. He was started on ruxolitnib, with decitabine added subsequently prior to definitive therapy with an allogenic haematopoietic stem cell transplant. His course with decitabine was complicated with febrile neutropaenia with multiple tender erythematous plaques unresponsive to antibacterial and antifungal coverage. A skin biopsy showed neutrophilic dermatitis, consistent with a diagnosis of Sweet’s syndrome (SS) and empirical treatment with glucocorticoids was initiated resulting in resolution of symptoms. This report reviews the literature for cases of SS in the setting of MF.